Get the Stockscreener App
4.95
2.17%
-0.11
After Hours:
4.95
ProPhase Labs Inc stock is currently priced at $4.95, with a 24-hour trading volume of 12,151.
It has seen a -2.17% decreased in the last 24 hours and a -20.16% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $5.19 pivot point. If it approaches the $4.92 support level, significant changes may occur.
Previous Close:
$5.06
Open:
$5.06
24h Volume:
12,151
Market Cap:
$89.32M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-18.33
EPS:
-0.27
Net Cash Flow:
$-13.77M
1W Performance:
-9.01%
1M Performance:
-20.16%
6M Performance:
+9.51%
1Y Performance:
-35.96%
1D Range:
$4.90
$5.2277
52W Range:
$4.05
$9.9412
ProPhase Labs Inc Stock (PRPH) Company Profile
Name
ProPhase Labs Inc
Sector
Industry
Phone
215-345-0919
Address
621 North Shady Retreat Road, Doylestown, PA
ProPhase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
ProPhase Labs Inc Stock (PRPH) Latest News
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
GlobeNewswire Inc.
ProPhase Labs Unveils Project ZenQ-AI
GlobeNewswire Inc.
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Zacks Investment Research
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
GlobeNewswire Inc.
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
GlobeNewswire Inc.
ProPhase Labs Inc Stock (PRPH) Financials Data
ProPhase Labs Inc (PRPH) Revenue 2024
PRPH reported a revenue (TTM) of $62.71 million for the quarter ending September 30, 2023, a -57.04% decline year-over-year.
ProPhase Labs Inc (PRPH) Net Income 2024
PRPH net income (TTM) was -$10.47 million for the quarter ending September 30, 2023, a -133.26% decrease year-over-year.
ProPhase Labs Inc (PRPH) Cash Flow 2024
PRPH recorded a free cash flow (TTM) of -$13.77 million for the quarter ending September 30, 2023, a -166.19% decrease year-over-year.
ProPhase Labs Inc (PRPH) Earnings per Share 2024
PRPH earnings per share (TTM) was -$0.63 for the quarter ending September 30, 2023, a -134.24% decline year-over-year.
About ProPhase Labs Inc
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
4.61%
Cap:
|
Volume (24h):